Why Myo-Inositol for PCOS Is the Quiet Supplement Story UK Women Should Know About in 2026

The most interesting story in UK women’s health right now is not happening on TikTok. It is happening in the supplements aisle of Holland & Barrett, where myo-inositol for PCOS has quietly become the supplement British women with polycystic ovary syndrome are picking up on the recommendation of friends, dietitians and the occasional well-read GP. There is no celebrity endorsement attached. No founder story. Just a sugar-alcohol compound your body already makes, sold in slightly underwhelming pouches, with a body of evidence that has been building for the better part of two decades.

That last bit is the point. Myo-inositol for PCOS is not new. What is new is that the UK market has caught up to the research, the price of a generic 40:1 powder has dropped under £20 a month, and enough British women have tried it – and stuck with it – that the word-of-mouth has finally outpaced the marketing budget. With Verity, the UK’s PCOS charity, estimating that around one in ten women of reproductive age has the condition, this matters.

What myo-inositol actually is

Myo-inositol is the most abundant of nine inositol isomers, a sugar alcohol your body manufactures from glucose and gets in smaller amounts from beans, citrus fruit, nuts and whole grains. It sits inside cell membranes and acts as a secondary messenger – essentially, a small molecule that helps cells respond properly to hormones like insulin, FSH and TSH. When that signalling works, your ovaries, thyroid and pancreas behave the way they should. When it does not, you get the cluster of symptoms women with PCOS know well.

Most PCOS researchers focus on two isomers: myo-inositol and D-chiro-inositol. They work together. The first improves how cells take up glucose and how ovarian follicles mature. The second helps moderate androgens – the testosterone-family hormones that drive acne, unwanted hair growth and irregular cycles.

Why PCOS responds to it

PCOS is not really an ovary problem. It is a metabolic-signalling problem that shows up most visibly in the ovaries. Around 70% of women with PCOS have some degree of insulin resistance, even at a healthy weight. Insulin resistance nudges the ovaries to make more testosterone, which disrupts ovulation, which produces the irregular cycles and small ovarian cysts that give the syndrome its name.

Myo-inositol is the strongest example of the “quiet supplement that has earned its evidence” category. The loud version, currently filling UK feeds, is berberine, marketed as “nature’s Ozempic”. The two are worth reading side by side – one is what hype looks like with real trials behind it, the other is what hype looks like without.

Here is where the honesty has to come in, because PCOS content online is full of overclaiming. The most thorough summary we have is the Cochrane review of inositol for PCOS and subfertility, which pooled 13 randomised controlled trials covering 1,472 women. It found signals that inositol improves some metabolic markers and may help ovulation, but rated the overall quality of evidence as low to very low, mostly because the trials were small and inconsistently reported. That is not a reason to dismiss it. It is a reason to hold the claims loosely.

What the same body of research does suggest is gentleness. The effect sizes are smaller than for metformin, the prescription drug typically offered, but the side-effect profile is far milder – and women who could not tolerate metformin’s gastrointestinal effects have stayed on inositol for years. The fact that inositol is something your body already makes, rather than a foreign molecule it has to clear, is part of why it tends to sit so easily. It is not a free pass. It is a different starting point.

The 40:1 ratio everyone talks about

The most studied protocol is 2g of myo-inositol plus 50mg of D-chiro-inositol, taken twice daily. That is the 40:1 ratio you will see across product labels. It is not arbitrary – it approximates the physiological ratio of the two isomers in plasma, and the trials that produced the strongest results in ovulation and metabolic markers used it.

This matters because the supplement aisle is full of myo-inositol-only formulations, often at higher doses. They are cheaper to make and not useless, but the bulk of trial evidence points to the combined 40:1 form. If you only see myo-inositol on the label, you are getting half the protocol.

UK pharmacies have only really stocked the combined ratio reliably since 2023. Before that, most British women bought it online from Italian or American suppliers – the ratio was developed and trialled mostly in Italy, where inositol has been used clinically for years.

Myo-inositol vs metformin vs berberine

These three get lumped together as “the insulin options” for PCOS, but they are not interchangeable. One is a prescription drug with decades of data. One is a well-evidenced supplement. One is mostly marketing with a thin clinical file. Here is the plain comparison.

	Myo-inositol (40:1)	Metformin	Berberine
Access	Over the counter	Prescription only	Over the counter
Evidence base	Multiple RCTs, but rated low-quality overall; encouraging for metabolic markers and ovulation	Strongest and longest track record for insulin resistance and menstrual regularity in PCOS	Lowers blood glucose and lipids in general trials; very little PCOS-specific RCT data
Typical timeframe	8–12 weeks for metabolic shifts; longer for cycles	Weeks to a few months	Weeks for glucose markers; PCOS outcomes unclear
Common downsides	Mild; occasional loose stools at high doses	GI upset, nausea, especially early on	GI upset; interacts with several prescription drugs
Rough monthly cost	£15–35	NHS prescription charge or pennies privately	£15–30

My read, for what it is worth: metformin is the one with the deepest evidence and it is free on prescription, so it is daft to skip a GP conversation just to buy a powder. Inositol earns its place as the gentler option, or as something to run alongside the basics. Berberine I would leave on the shelf for now – it interacts with too many medicines and the PCOS-specific evidence simply is not there yet, whatever the “nature’s Ozempic” label implies.

What UK guidelines actually say

The NHS page on PCOS still leads with weight management, the combined contraceptive pill and metformin. Inositol is not currently part of the standard NHS pathway, which is a frustration to many UK PCOS researchers and to plenty of women who have already tried the conventional route.

The most recent international PCOS guideline, whose 2023 update was informed by a fresh systematic review and endorsed by bodies including the British Fertility Society, does mention inositol – but as something that may be considered, with the caveat that the evidence base, while encouraging, is still maturing. NICE has not recommended it as a first-line option. The honest summary: the evidence is good enough that informed clinicians recommend it privately, but not so settled that public-health bodies have put it in the formal pathway.

In practice this means: if you are considering myo-inositol for PCOS, talk to your GP, especially if you are also taking metformin, the combined pill or thyroid medication, all of which interact in subtle ways.

What it costs, and which UK product to buy

Prices have settled into two tiers. Generic combined 40:1 powders – the Ovasitol-style tubs, plus own-brand versions now on Amazon UK and iHerb – work out at roughly £15–25 a month if you buy a two or three-month tub. Branded sachet formulations like Inofolic Alpha sit higher, around £30–35 a month, because they add alpha-lactalbumin (which is meant to improve absorption) and folic acid, and they come pre-portioned. Whether the absorption upgrade is worth the premium is genuinely unsettled, so I would start cheap and only trade up if the basic powder does nothing.

A few things to check on any label before you commit to a six-month supply:

• The 40:1 ratio, stated as roughly 2g myo-inositol to 50mg D-chiro-inositol per serving, taken twice daily.
• Third-party testing, ideally with a certificate of analysis available on request. Several UK-stocked brands now publish these.
• No added stevia or flavourings if you are sensitive – the powder is mildly sweet on its own.
• A per-serve dose that actually matches the trial protocol. Capsule formats often need six-plus capsules a day to get there, which gets tedious fast.

Powder beats capsules for most people, simply because hitting 4g a day in capsule form is a chore. It dissolves into water or juice without much fuss.

Practical considerations before you start

Dose timing matters. Inositol is taken in two equal doses – typically one in the morning, one in the evening, ideally with a meal. It is water-soluble and mildly sweet, and most powders dissolve into drinks without much fuss.

Give it a proper trial. Studies show metabolic markers shifting in around 8-12 weeks. Ovulatory cycles often take longer to regularise. Quitting at week four because nothing dramatic happened is a common mistake. Track cycles, sleep and skin in a simple journal. Some readers find catching the temperature shifts that signal returning ovulation easier with a wearable; our take on smart rings in 2026 covers what is actually useful.

Mind the obvious traps. Inositol is not a substitute for the basics. PCOS responds best to a combination of strength work, sleep, protein intake and, where relevant, weight loss. If you are layering it onto a chaotic lifestyle, expect modest gains. If you are pairing it with strength training – cycle-syncing your workouts, prioritising sleep and managing stress, which raises cortisol and worsens insulin signalling (our piece on cortisol face covers the cortisol-skin link in more detail) – the supplement does what supplements do well, which is amplify the rest. Two cheap levers most women under-use: getting protein up at breakfast (the fibre and protein angle blunts the glucose spikes that feed insulin resistance) and adding creatine if you are lifting, which makes the strength work land harder.

Myths worth clearing up

A few claims follow inositol around the internet that the evidence does not support.

“It fixes your thyroid.” It does not, at least not in any way the trial evidence backs for hypothyroidism. The thyroid story is more nuanced and mostly extrapolated from small studies. Treat it as unproven.

“More is better.” Mega-dosing myo-inositol on its own is not the trialled protocol, and skipping the D-chiro-inositol portion throws away the 40:1 logic that the research is built on. Higher doses mostly buy you looser stools.

“It works for every type of PCOS.” Women whose PCOS is driven by very high androgens, or the leaner phenotype without much insulin resistance, often see smaller benefits. The biggest responders tend to be those with clear metabolic involvement.

When myo-inositol for PCOS does not help

Myo-inositol is not magic. If your PCOS phenotype is driven by very high androgens with severe acne and hirsutism, you will likely need something else alongside it – a topical, a specific antiandrogen, or in some cases the combined pill, prescribed and monitored. Women who are not insulin-resistant – the so-called “lean PCOS” phenotype – sometimes see smaller benefits from inositol than women with more pronounced metabolic involvement, though the picture is mixed.

And it does not replace the basics: regular cycles need adequate protein, regular movement, decent sleep and the kind of slow nutritional consistency the wellness industry never quite manages to make exciting.

The honest pros and cons

Worth it if: you have PCOS with a metabolic component, you have run the basics for a few months without much change, you could not tolerate metformin, or you want a low-risk thing to run alongside lifestyle work while you wait on a GP appointment.

Probably not worth it if: you are chasing a quick fix, your PCOS is androgen-driven rather than insulin-driven, or you are hoping it replaces strength training, sleep and protein. It will not.

A reasonable place to land

If you have PCOS, are over 18, are not pregnant or breastfeeding, and have run the basics for three months without much change, myo-inositol for PCOS is one of the few supplements with a decent enough evidence base to warrant a structured 12-week trial – alongside, not instead of, the rest of your plan. Tell your GP. Buy the 40:1 ratio. Take it twice daily. Track what changes.

The supplement industry has produced enough nonsense over the years that quiet, well-evidenced products tend to get drowned out by the loud ones. Myo-inositol is one of the quieter stories. It is also one of the more useful ones, as long as you keep your expectations the same size as the evidence.

For another supplement with a genuine trial record, see our piece on saffron supplements.

This article is general information, not medical advice. Speak to your GP or pharmacist before starting any supplement, particularly if you are taking other medication.

Have you tried myo-inositol for your PCOS, and did the 12-week mark feel like a turning point or a flat line?